NeuBase Therapeutics, Inc.

De la TradeVille.ro wiki
Versiunea din 2 octombrie 2024 08:37, autor: 127.0.0.1 (discuție) (The LinkTitles extension automatically added links to existing pages (https://github.com/bovender/LinkTitles).)
(dif) ← Versiunea anterioară | Versiunea curentă (dif) | Versiunea următoare → (dif)

Pagina dedicata companiei NeuBase Therapeutics, Inc. listata cu simbolul US.NBSE

Descriere companie

NeuBase Therapeutics, Inc. (https://www.neubasetherapeutics.com/) is a pre-clinical-stage biopharmaceutical company. The Company is focused on developing therapies to treat rare genetic diseases and cancers caused by mutant genes. The Company’s peptide-nucleic acid antisense oligonucleotide (PATrOL) platform focuses on addressing Huntington's disease (HD) and myotonic dystrophy, as well as other genetic disorders. Its programs include NT0100, a PATrOL-enabled therapeutic program for systemic administration to target the mutant expansion in the HD messenger ribonucleic acid (mRNA) and NT0200, a PATrOL-enabled therapeutic program for systemic administration to target the mutant expansion in the myotonic dystrophy type one disease mRNA.

Grafic actiuni companie

Ultimele stiri despre NeuBase Therapeutics, Inc. (US.NBSE)

Adus de la „https://wiki.tradeville.ro/index.php?title=NeuBase_Therapeutics,_Inc.&oldid=448769”